134 related articles for article (PubMed ID: 35578724)
21. APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF.
Choi YD; Jung JY; Baek M; Khan S; Song PI; Ryu S; Koo JY; Chauhan SC; Tsin A; Choi C; Kim WJ; Kim M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438692
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
Wiseman DA; Werner SR; Crowell PL
J Pharmacol Exp Ther; 2007 Mar; 320(3):1163-70. PubMed ID: 17138864
[TBL] [Abstract][Full Text] [Related]
23. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.
Motomura W; Tanno S; Takahashi N; Nagamine M; Fukuda M; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2005 Jun; 332(1):89-94. PubMed ID: 15896303
[TBL] [Abstract][Full Text] [Related]
24. The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.
Cheng F; McLaughlin PJ; Verderame MF; Zagon IS
Mol Cancer; 2008 Jan; 7():5. PubMed ID: 18190706
[TBL] [Abstract][Full Text] [Related]
25. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
26. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
27. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer.
Liu Y; Qin P; Wu R; Du L; Li F
Hum Cell; 2020 Oct; 33(4):1186-1196. PubMed ID: 32700262
[TBL] [Abstract][Full Text] [Related]
28. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
29. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
30. High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Zhang Z; Xie H; Zhu S; Chen X; Yu J; Shen T; Li X; Shang Z; Niu Y
Med Sci Monit; 2018 Nov; 24():8190-8197. PubMed ID: 30427826
[TBL] [Abstract][Full Text] [Related]
31. Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.
Zhu X; Shi C; Peng Y; Yin L; Tu M; Chen Q; Hou C; Li Q; Miao Y
Cell Prolif; 2018 Jun; 51(3):e12428. PubMed ID: 29266545
[TBL] [Abstract][Full Text] [Related]
32. SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition.
Aguilar-Valdés A; Noriega LG; Tovar AR; Ibarra-Sánchez MJ; Sosa-Hernández VA; Maravillas-Montero JL; Martínez-Aguilar J
Biochem Biophys Res Commun; 2021 May; 552():23-29. PubMed ID: 33740661
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.
Yu Y; Wang XY; Sun L; Wang YL; Wan YF; Li XQ; Feng YM
Carcinogenesis; 2014 Jun; 35(6):1416-25. PubMed ID: 24626146
[TBL] [Abstract][Full Text] [Related]
34. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Colon Cancer.
Li B; Zhu FC; Yu SX; Liu SJ; Li BY
Cancer Biother Radiopharm; 2020 Feb; 35(1):50-57. PubMed ID: 31657617
[No Abstract] [Full Text] [Related]
35. LncRNA RPPH1 predicts poor prognosis and regulates cell proliferation and migration by repressing P21 expression in gastric cancer.
Yue K; Ma JL; Jiang T; Yue J; Sun SK; Shen JL; Miao Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11072-11080. PubMed ID: 33215423
[TBL] [Abstract][Full Text] [Related]
36. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53.
Yadav V; Sultana S; Yadav J; Saini N
PLoS One; 2012; 7(10):e47796. PubMed ID: 23133524
[TBL] [Abstract][Full Text] [Related]
37. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways.
Tu Y; Wu W; Wu T; Cao Z; Wilkins R; Toh BH; Cooper ME; Chai Z
J Biol Chem; 2007 Apr; 282(16):11722-31. PubMed ID: 17317670
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin.
Zhang J; Lan Z; Qiu G; Ren H; Zhao Y; Gu Z; Li Z; Feng L; He J; Wang C
BMC Cancer; 2020 Nov; 20(1):1065. PubMed ID: 33148205
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
